Resmed Inc. buy Royal Bank of Canada
Start price
30.01.26
/
50%
€222.50
Target price
30.01.27
-
Performance (%)
-4.94%
Price
11:42
€211.50
Summary
This prediction is currently active. With a performance of -4.94%, the BUY prediction for Resmed Inc. by Royal_Bank_of_Canada is down slightly. This prediction currently runs until 30.01.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Resmed Inc. | -1.019% |
| iShares Core DAX® | 0.024% |
| iShares Nasdaq 100 | 1.740% |
| iShares Nikkei 225® | 0.428% |
| iShares S&P 500 | 1.329% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Resmed Inc. diskutieren
ResMed (NYSE:RMD) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
Ratings data for RMD provided by MarketBeat